Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience

References

• Aguilera G, Liu Y. The molecular physiology of CRH neurons. Front Neuroendocrinol 2012;33:67-84
   PubMed Web of Science ®Google Scholar
• Clifton VL, Read MA, Leitch IM, et al. Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation. J Clin Endocrinol Metab 1994;79:666-9
   PubMed Web of Science ®Google Scholar
• Glantz A, Marschall HU, Lammert F, et al. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005;42:1399-405
   PubMed Web of Science ®Google Scholar
• Kenyon AP, Girling JC. Obstetrics Cholestasis. RCOG Green-top guidelines No 43. London: RCOG, 2011
   Google Scholar
• Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 2004;40:467-74
   PubMed Web of Science ®Google Scholar
• Chappell LC, Gurung V, Seed PT, et al. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomized clinical trial. BMJ 2012;344:e3799
   PubMed Web of Science ®Google Scholar
• Kondrackiene J, Beuers U, Kupcinskas L. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 2005;129:894-901
   PubMed Web of Science ®Google Scholar
• Zapata R, Sandoval L, Palma J, et al. Ursodeoxycholic acid in the treatment of intrahepatic cholestatis of pregnancy, a 12-year experience. Liver Int 2005;25:548-54
   PubMed Web of Science ®Google Scholar
• Zhou F, He MM, Liu ZF, et al. Expression of corticotrophin-releasing hormone and its receptor in patients with intrahepatic cholestasis of pregnancy. Placenta 2013;34:401-6
   PubMed Web of Science ®Google Scholar
• Roncaglia N, Locatelli A, Arreghini A, et al. A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis. Br J Obstet Gynaecol 2004;111:17-21
   Google Scholar
• Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002;36:525-31
   PubMed Web of Science ®Google Scholar
• Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid mechanisms of action and clinical use in hepatobiliary disorders. J Hepatol 2001;35:134-46
   PubMed Web of Science ®Google Scholar
• Fickert P, Zollner G, Fushsbichler A, et al. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 2001;121:170-83
   PubMed Web of Science ®Google Scholar
• Davidson SM, Rybka AE, Townsend PA. The powerful cardioprotective effects of urocortin and the corticotrophin releasing hormone (CRH) family. Biochem Pharmacol 2009;77:141-50
   PubMed Web of Science ®Google Scholar
• Mazzella G, Rizzo N, Azzaroli F, et al. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology 2001;33:504-8
   PubMed Web of Science ®Google Scholar
• Serrano MA, Brites D, Larena MG, et al. Beneficial effect of ursodeoxycholic acid on alterations induced by cholestasis of pregnancy in bile acid transport across the human placenta. J Hepatol 1998;28:829-39
   PubMed Web of Science ®Google Scholar
• Azzaroli F, Mehal W, Soroka CJ, et al. Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes. Hepatology 2002;36:49-54
   PubMed Web of Science ®Google Scholar
• Petraglia F, Imperatore A, Challis JR. Neuroendocrine mechanisms in pregnancy and parturition. Endocr Rev 2010;31:783-816
   PubMed Web of Science ®Google Scholar
• Goland RS, Wardlaw SL, Stark RI, et al. High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy. J Clin Endocrinol Metab 1986;63:1199-203
   PubMed Web of Science ®Google Scholar
• Harville EW, Savitz DA, Dole N, et al. Stress and placental resistance measured by Doppler ultrasound in early and mid-pregnancy. Ultrasound Obstet Gynecol 2008;32:23-30
   PubMed Web of Science ®Google Scholar
• Cheng YH, Handwerger S. Mitogen-activated protein kinase activation induces corticotrophin releasing hormone gene expression in human placenta. Life Sci 2005;77:1263-72
   PubMed Web of Science ®Google Scholar
• Cheng YH, Nicholson RC, King B, et al. Corticotropin-releasing hormone gene expression in primary placental cells is modulated by cyclic adenosine 3′,5′-monophosphate. J Clin Endocr Metab 2000;85:1239-44
   PubMed Web of Science ®Google Scholar
• Woods RJ, Grossman A, Saphier P, et al. Association of human corticotropin-releasing hormone to its binding protein in blood may trigger clearance of the complex. J Clin Endocrinol Metab 1994;78:73-6
   PubMed Web of Science ®Google Scholar
• Perkins AV, Eben F, Wolfe CD, et al. Plasma measurements of corticotrophin-releasing hormone-binding protein in normal and abnormal human pregnancy. J Endocrinol 1993;138:149-57
   PubMedGoogle Scholar